Advertisement

Malaria vaccine should be given to children across Africa: WHO

Click to play video: 'WHO recommends first ever malaria vaccine, marking major step in fight against disease' WHO recommends first ever malaria vaccine, marking major step in fight against disease
WATCH: On Wednesday, the World Health Organization (WHO) recommended the first ever vaccine for the prevention of malaria. Officials with the organization called it a “glimmer of hope” for Africa. The WHO recommendation is for RTS,S, or Mosquirix, a vaccine developed by British drugmaker GlaxoSmithKline – Oct 6, 2021

The World Health Organization recommended Wednesday that the world’s first malaria vaccine should be given to children across Africa, in a move officials hope will spur stalled efforts to curb the spread of the parasitic disease.

Following a meeting of the United Nations health agency’s vaccine advisory group, WHO director-general Tedros Adhanom Ghebreyesus spoke of “a historic moment.”

Read more: Malaria deaths still at ‘unacceptably high levels’ worldwide, WHO says

“Today’s recommendation offers a glimmer of hope for the continent which shoulders the heaviest burden of the disease and we expect many more African children to be protected from malaria and grow into healthy adults,” said Dr. Matshidiso Moeti, the WHO’s Africa director.

The WHO said its decision was based on results from ongoing research in Ghana, Kenya and Malawi that has tracked more than 800,000 children since 2019.

Story continues below advertisement

Read more: Scientists could soon fight malaria with ‘mosquito birth control’

 

The malaria vaccine known as Mosquirix was developed by GlaxoSmithKline in 1987. While it’s the first to be authorized, it is only about 30% effective, requires up to four doses, and protection fades after just months.

Still, given the extremely high burden of malaria in Africa, where the majority of the world’s more than 200 million cases a year and 400,000 deaths occur, scientists say the vaccine could still have a major impact.

Click to play video: 'Can genetically-modified mosquitoes help fight vector-borne diseases like Malaria?' Can genetically-modified mosquitoes help fight vector-borne diseases like Malaria?
Can genetically-modified mosquitoes help fight vector-borne diseases like Malaria? – Jul 8, 2021

“This is a huge step forward,” said Julian Rayner, director of the Cambridge Institute for Medical Research, who was not part of the WHO decision. “It’s an imperfect vaccine, but it will still stop hundreds of thousands of children from dying.” Rayner said that the vaccine’s impact on the spread of the mosquito-borne disease was still unclear, but pointed to the coronavirus vaccines as an encouraging example.

Story continues below advertisement

“The last two years have given us a very nuanced understanding of how important vaccines are in saving lives and reducing hospitalizations, even if they don’t directly reduce transmission.”

Read more: Mosquitoes are on the move due to climate change, and they could bring diseases

Sian Clarke, co-director of the Malaria Centre at the London School of Hygiene and Tropical Medicine, said the vaccine would be a useful addition to other tools against the disease that might have exhausted their utility after decades of use, like bednets and insecticides.

Click to play video: 'This is the world’s deadliest predator' This is the world’s deadliest predator
This is the world’s deadliest predator – Nov 5, 2019

“In some countries where it gets really hot, children just sleep outside, so they can’t be protected by a bednet,” Clarke explained. “So obviously if they’ve been vaccinated, they will still be protected.”

Clarke added that in the last few years little significant progress has been made against malaria. “If we’re going to decrease the disease burden now, we need something else.”

Advertisement

Sponsored content